Eliem Therapeutics, Inc. (ELYM)

NASDAQ: ELYM · IEX Real-Time Price · USD
3.43
-0.03 (-0.87%)
May 20, 2022 4:00 PM EDT - Market closed

Total Valuation

ELYM has a market cap or net worth of $91.13 million. The enterprise value is -$45.35 million.

Market Cap91.13M
Enterprise Value-45.35M

Important Dates

The next earnings date is Monday, June 6, 2022, before market open.

Estimated Earnings DateJun 6, 2022
Ex-Dividend Daten/a

Share Statistics

ELYM has 26.57 million shares outstanding. The number of shares has increased by 460.40% in one year.

Shares Outstanding26.57M
Shares Change (YoY)+460.40%
Shares Change (QoQ)-21.33%
Owned by Insiders (%)33.19%
Owned by Institutions (%)72.45%
Float2.21M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio0.55
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

Current Ratio24.58
Quick Ratio22.63
Debt / Equity0.00
Debt / EBITDA0.00
Debt / FCF0.00

Financial Efficiency

Return on equity (ROE) is -83.30%, which is considered low. The company has a ROIC of -79.70%.

Return on Equity (ROE)-83.30%
Return on Assets (ROA)-40.30%
Return on Capital (ROIC)-79.70%
Revenue Per Employeen/a
Profits Per Employee-$1.41M
Employee Count37
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-72.56%
50-Day Moving Average5.50
200-Day Moving Average9.74
Average Volume (30 Days)197,398

Short Selling Information

The latest short interest is 1.05 million, so 3.94% of the outstanding shares have been sold short.

Short Interest1.05M
Short % of Shares Out3.94%
Short % of Float47.39%
Short Ratio (days to cover)3.91

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-35.67M
Net Income-47.48M
Net Income Common-52.03M
EBITDA-47.48M
EBIT-47.48M
Earnings Per Share (EPS)-$2.54
Full Income Statement

Balance Sheet

The company has $136.48 million in cash and no debt, giving a net cash position of $136.48 million or $5.14 per share.

Cash & Cash Equivalents136.48M
Total Debt0
Net Cash136.48M
Net Cash Per Share$5.14
Book Value167.20M
Book Value Per Share6.29
Working Capital142.22M
Full Balance Sheet

Cash Flow

Operating Cash Flow-36.07M
Capital Expendituresn/a
Free Cash Flow-36.07M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

ELYM does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-57.09%
FCF Yield-39.58%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-460.40%
Shareholder Yield-460.40%
Dividend Details

Analyst Forecast

The average price target for ELYM is $24.48, which is 613.70% higher than the current price. The consensus rating is "Buy".

Price Target$24.48
Price Target Difference613.70%
Analyst ConsensusBuy
Analyst Count10
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a